Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors | SpringerLink
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience | Anticancer Research
Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy - Advances in Radiation Oncology
Cureus | Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response | Article
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer - Advances in Radiation Oncology
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
Assessment of The breast After Neoadjuvant Treatment
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis - ScienceDirect
Imaging, biomarkers after first neoadjuvant chemotherapy treatment cycle predicts treatment outcome, study finds | McKelvey School of Engineering at Washington University in St. Louis
The concept of neoadjuvant therapy in breast cancer - OWise UK
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited | Semantic Scholar
Frontiers | Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges - Annals of Oncology
